Letter from the Editor-in-Chief: Neurotherapeutics’ Transition to Gold Open Access

Letter from the Editor-in-Chief: Neurotherapeutics’ Transition to Gold Open Access

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neurotherapeutics 2023-10, Vol.20 (6), p.1427-1427
1. Verfasser: Mouradian, M. Maral
Format: Artikel
Sprache:eng
Schlagworte:
Biomedical and Life Sciences
Biomedicine
Editorial
Neurobiology
Neurology
Neurosciences
Neurosurgery
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1427
container_issue 6
container_start_page 1427
container_title Neurotherapeutics
container_volume 20
creator Mouradian, M. Maral
description
doi_str_mv 10.1007/s13311-023-01439-4
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10684434</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2894585852</sourcerecordid><originalsourceid>FETCH-LOGICAL-c426t-b29bda4fb6a64953fae28057a7cecc74b48412037fa60c2c6118e08c314a02303</originalsourceid><addsrcrecordid>eNp9kb1uFDEUhS0EIiHwAhTIEk0ag_9mbNOgaBUC0oo0m9ryeO9kHc3ai-1Bostr5PXyJDhsCD9F5MKWzudz79FB6DWj7xil6n1hQjBGKBeEMikMkU_QIdNKEyWVedreRgiiOBMH6EUpV5R2Qhj9HB0IpTpGlTpEqyXUChmPOW1x3QA-XYeaMgmRLDYBxg_4K8w5NSW7Hcw1-HJ7fYNX2cUSakgR14TP0rTG5zuI-MR7KOUleja6qcCr-_sIXXw6XS0-k-X52ZfFyZJ4yftKBm6GtZPj0Ltemk6MDrimnXLKg_dKDlJLxqlQo-up575nTAPVXjDpWmgqjtDHve9uHraw9hBrdpPd5bB1-YdNLth_lRg29jJ9t4z2Wkohm8PxvUNO32Yo1W5D8TBNLkKai-W6N5wz1ZuGvv0PvUpzji1fo4zsdDu8UXxP-ZxKyTA-bMOovWvN7luzLYD91Zq92-LN3zkevvyuqQFiD5QmxUvIf2Y_YvsTOROjQg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2894585852</pqid></control><display><type>article</type><title>Letter from the Editor-in-Chief: Neurotherapeutics’ Transition to Gold Open Access</title><source>SpringerLink (Online service)</source><source>PubMed (Medline)</source><source>Alma/SFX Local Collection</source><source>EZB Electronic Journals Library</source><creator>Mouradian, M. Maral</creator><creatorcontrib>Mouradian, M. Maral</creatorcontrib><identifier>ISSN: 1933-7213</identifier><identifier>ISSN: 1878-7479</identifier><identifier>EISSN: 1878-7479</identifier><identifier>DOI: 10.1007/s13311-023-01439-4</identifier><identifier>PMID: 37751077</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Biomedical and Life Sciences ; Biomedicine ; Editorial ; Neurobiology ; Neurology ; Neurosciences ; Neurosurgery</subject><ispartof>Neurotherapeutics, 2023-10, Vol.20 (6), p.1427-1427</ispartof><rights>The American Society for Experimental Neurotherapeutics, Inc. 2023</rights><rights>The American Society for Experimental Neurotherapeutics, Inc. 2023.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684434/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684434/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,315,728,781,785,886,27926,27927,41490,42559,51321,53793,53795</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37751077$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mouradian, M. Maral</creatorcontrib><title>Letter from the Editor-in-Chief: Neurotherapeutics’ Transition to Gold Open Access</title><title>Neurotherapeutics</title><addtitle>Neurotherapeutics</addtitle><addtitle>Neurotherapeutics</addtitle><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Editorial</subject><subject>Neurobiology</subject><subject>Neurology</subject><subject>Neurosciences</subject><subject>Neurosurgery</subject><issn>1933-7213</issn><issn>1878-7479</issn><issn>1878-7479</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kb1uFDEUhS0EIiHwAhTIEk0ag_9mbNOgaBUC0oo0m9ryeO9kHc3ai-1Bostr5PXyJDhsCD9F5MKWzudz79FB6DWj7xil6n1hQjBGKBeEMikMkU_QIdNKEyWVedreRgiiOBMH6EUpV5R2Qhj9HB0IpTpGlTpEqyXUChmPOW1x3QA-XYeaMgmRLDYBxg_4K8w5NSW7Hcw1-HJ7fYNX2cUSakgR14TP0rTG5zuI-MR7KOUleja6qcCr-_sIXXw6XS0-k-X52ZfFyZJ4yftKBm6GtZPj0Ltemk6MDrimnXLKg_dKDlJLxqlQo-up575nTAPVXjDpWmgqjtDHve9uHraw9hBrdpPd5bB1-YdNLth_lRg29jJ9t4z2Wkohm8PxvUNO32Yo1W5D8TBNLkKai-W6N5wz1ZuGvv0PvUpzji1fo4zsdDu8UXxP-ZxKyTA-bMOovWvN7luzLYD91Zq92-LN3zkevvyuqQFiD5QmxUvIf2Y_YvsTOROjQg</recordid><startdate>20231001</startdate><enddate>20231001</enddate><creator>Mouradian, M. Maral</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20231001</creationdate><title>Letter from the Editor-in-Chief: Neurotherapeutics’ Transition to Gold Open Access</title><author>Mouradian, M. Maral</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c426t-b29bda4fb6a64953fae28057a7cecc74b48412037fa60c2c6118e08c314a02303</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Editorial</topic><topic>Neurobiology</topic><topic>Neurology</topic><topic>Neurosciences</topic><topic>Neurosurgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mouradian, M. Maral</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database (ProQuest)</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Psychology Database (ProQuest)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Neurotherapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mouradian, M. Maral</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Letter from the Editor-in-Chief: Neurotherapeutics’ Transition to Gold Open Access</atitle><jtitle>Neurotherapeutics</jtitle><stitle>Neurotherapeutics</stitle><addtitle>Neurotherapeutics</addtitle><date>2023-10-01</date><risdate>2023</risdate><volume>20</volume><issue>6</issue><spage>1427</spage><epage>1427</epage><pages>1427-1427</pages><issn>1933-7213</issn><issn>1878-7479</issn><eissn>1878-7479</eissn><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>37751077</pmid><doi>10.1007/s13311-023-01439-4</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1933-7213
ispartof Neurotherapeutics, 2023-10, Vol.20 (6), p.1427-1427
issn 1933-7213
1878-7479
1878-7479
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10684434
source SpringerLink (Online service); PubMed (Medline); Alma/SFX Local Collection; EZB Electronic Journals Library
subjects Biomedical and Life Sciences
Biomedicine
Editorial
Neurobiology
Neurology
Neurosciences
Neurosurgery
title Letter from the Editor-in-Chief: Neurotherapeutics’ Transition to Gold Open Access
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T19%3A54%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Letter%20from%20the%20Editor-in-Chief:%20Neurotherapeutics%E2%80%99%20Transition%20to%20Gold%20Open%20Access&rft.jtitle=Neurotherapeutics&rft.au=Mouradian,%20M.%20Maral&rft.date=2023-10-01&rft.volume=20&rft.issue=6&rft.spage=1427&rft.epage=1427&rft.pages=1427-1427&rft.issn=1933-7213&rft.eissn=1878-7479&rft_id=info:doi/10.1007/s13311-023-01439-4&rft_dat=%3Cproquest_pubme%3E2894585852%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2894585852&rft_id=info:pmid/37751077&rfr_iscdi=true